Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Standard of Care × 90 days × Clear all

Sponsor

Conditions

Neoplasms 12 Colorectal Neoplasms 12 Breast Neoplasms 10 Prostatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Neoplasm Metastasis 6 Hematologic Neoplasms 6 Hematopoietic and Lymphatic System Neoplasm 5 Urinary Bladder Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Ovarian Neoplasms 4 Breast Carcinoma In Situ 4 Sarcoma 3 Motor Activity 3 Leukemia, Myeloid, Acute 3 Stomach Neoplasms 2 Pathologic Complete Response 2 Osteosarcoma 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Melanoma 2 Lymphoma, Follicular 2 Lymphedema 2 Hemangiosarcoma 2 Head and Neck Neoplasms 2 Frailty 2 Fallopian Tube Neoplasms 2 Carcinoma, Squamous Cell 2

Interventions

Bevacizumab 24 atezolizumab 19 durvalumab 18 Specimen Handling 15 pembrolizumab 12 lenvatinib 11 Magnetic Resonance Spectroscopy 11 tremelimumab 10 Nivolumab 10 Sorafenib 8 Radiosurgery 8 Cyclophosphamide 6 camrelizumab 5 apatinib 5 Ipilimumab 5 tislelizumab 4 regorafenib 4 fludarabine 4 cabozantinib 4 X-Rays 4 Immunoglobulin G 4 sintilimab 3 gadolinium ethoxybenzyl DTPA 3 Immune Checkpoint Inhibitors 3 Ethiodized Oil 3 E-7386 3 Disulfides 3 Blood Specimen Collection 3 Biopsy 3 gadobutrol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡